These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2508416)

  • 1. Characterization of acetylcholine receptor antibodies in a patient with primary biliary cirrhosis.
    Lefvert AK; Holm G
    Acta Neurol Scand; 1989 Sep; 80(3):255-8. PubMed ID: 2508416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acetylcholine receptor antibodies in primary biliary cirrhosis: characterization of antigen and idiotypic specificity.
    Sundewall AC; Lefvert AK
    Scand J Immunol; 1990 Apr; 31(4):477-84. PubMed ID: 1692155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of anti-acetylcholine receptor antibody activity in patients with anti-mitochondrial antibodies.
    Sundewall AC; Lefvert AK; Norberg R
    Clin Immunol Immunopathol; 1987 Nov; 45(2):184-95. PubMed ID: 3665199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine receptor antibody positive generalized myasthenia gravis in association with primary biliary cirrhosis.
    Taddy H; Yoshida EM; Gibson G; Chatur N
    Ann Hepatol; 2010; 9(4):471-2. PubMed ID: 21057170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-acetylcholine receptor antibodies in primary biliary cirrhosis.
    Sundewall AC; Lefvert AK; Olsson R
    Acta Med Scand; 1985; 217(5):519-25. PubMed ID: 4025008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myasthenia gravis and primary biliary cirrhosis. Common immunological features and rare coincidence.
    Kiechl S; Kohlendorfer U; Willeit J; Pohl P; Vogel W
    Acta Neurol Scand; 1996 Apr; 93(4):263-5. PubMed ID: 8739436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical characterization of anti-acetylcholine receptor antibodies in primary biliary cirrhosis.
    Kyriatsoulis A; Manns M; Gerken G; Lohse AW; Maelicke A; Wessler I; Reske K; Meyer zum Büschenfelde KH
    J Hepatol; 1988 Jun; 6(3):283-90. PubMed ID: 3292637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunopathology of myasthenia gravis.
    Lennon VA
    Hum Pathol; 1978 Sep; 9(5):541-51. PubMed ID: 309428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive transfer models of myasthenia gravis with muscle-specific kinase antibodies.
    Verschuuren JJGM; Plomp JJ; Burden SJ; Zhang W; Fillié-Grijpma YE; Stienstra-van Es IE; Niks EH; Losen M; van der Maarel SM; Huijbers MG
    Ann N Y Acad Sci; 2018 Feb; 1413(1):111-118. PubMed ID: 29356029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN; Reddel SW; Gervásio OL; Phillips WD
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies against the acetylcholine receptor also in nonmyasthenic autoimmune disease.
    Sundewall AC; Lefvert K
    Ann N Y Acad Sci; 1988; 540():525-7. PubMed ID: 3207283
    [No Abstract]   [Full Text] [Related]  

  • 13. [Heterogeneity of acetylcholine receptor antibodies in patients with myasthenia gravis].
    Kalies I; Heinz F; Kaschka WP; Druschky KF; Kalden JR
    Klin Wochenschr; 1984 Apr; 62(8):377-85. PubMed ID: 6727277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for pre-clinical assessment of the acetylcholine receptor--specific passive transfer myasthenia gravis model-Recommendations for methods and experimental designs.
    Kusner LL; Losen M; Vincent A; Lindstrom J; Tzartos S; Lazaridis K; Martinez-Martinez P
    Exp Neurol; 2015 Aug; 270():3-10. PubMed ID: 25743217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Myasthenia gravis induced by autoantibodies against MuSK].
    Shigemoto K; Konishi T; Ohta M
    Nihon Rinsho; 2008 Jun; 66(6):1149-54. PubMed ID: 18540361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ganglionic acetylcholine receptor autoantibodies in patients with autoimmune diseases including primary biliary cirrhosis.
    Maeda Y; Nakane S; Higuchi O; Nakamura H; Komori A; Migita K; Mukaino A; Umeda M; Ichinose K; Tamai M; Kawashiri SY; Sakai W; Yatsuhashi H; Kawakami A; Matsuo H
    Mod Rheumatol; 2017 Jul; 27(4):664-668. PubMed ID: 27538899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A triple antibody assay for the quantitation of plasma IgG subclass antibodies to acetylcholine receptors in patients with myasthenia gravis.
    Nielsen FC; Rødgaard A; Djurup R; Somnier F; Gammeltoft S
    J Immunol Methods; 1985 Nov; 83(2):249-58. PubMed ID: 3902978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional activities of autoantibodies to acetylcholine receptors and the clinical severity of myasthenia gravis.
    Drachman DB; Adams RN; Josifek LF; Self SG
    N Engl J Med; 1982 Sep; 307(13):769-75. PubMed ID: 7110241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum Acetylcholine Receptor Antibodies Before the Clinical Onset of Myasthenia Gravis.
    Strijbos E; Verschuuren JJGM; Kuks JBM
    J Neuromuscul Dis; 2018; 5(2):261-264. PubMed ID: 29865092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects.
    Viegas S; Jacobson L; Waters P; Cossins J; Jacob S; Leite MI; Webster R; Vincent A
    Exp Neurol; 2012 Apr; 234(2):506-12. PubMed ID: 22326541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.